Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues

作者: William J. Polvino

DOI:

关键词:

摘要: The present invention relates to a method of stimulating the motility gastrointestinal system in subject need thereof, wherein suffers from maladies (i.e., disorders or diseases) system. comprises administering thereof therapeutically effective amount growth hormone secretagogue compound pharmaceutically acceptable salt, hydrate solvate thereof. can be co-administered with laxative, H2 receptor antagonist, serotonin 5-HT4 agonist, an antacid, opioid proton pump inhibitor, motilin dopamine cholinergic cholinesterase somatostatin, octreotide, any combination

参考文章(18)
Robin Spiller, Serotonergic modulating drugs for functional gastrointestinal diseases. British Journal of Clinical Pharmacology. ,vol. 54, pp. 11- 20 ,(2002) , 10.1046/J.1365-2125.2002.01612.X
Proost Eddy André Josée de, Prucalopride oral solution ,(2000)
Hamid R. Hoveyda, Mark L. Peterson, Graeme L. Fraser, Methods of using macrocyclic modulators of the ghrelin receptor ,(2005)
Y.-L. Liu, N. M. Malik, G. J. Sanger, P. L. R. Andrews, Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents. Cancer Chemotherapy and Pharmacology. ,vol. 58, pp. 326- 333 ,(2006) , 10.1007/S00280-005-0179-0
Carmelo Scarpignato, Pharmacological Stimulation of Gastrointestinal Motility: Where We Are and Where Are We Going? Digestive Diseases. ,vol. 15, pp. 112- 136 ,(1997) , 10.1159/000171626
John A. Rudd, Man P. Ngan, Man K. Wai, Andrew G. King, Jason Witherington, Paul L.R. Andrews, Gareth J. Sanger, Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin Neuroscience Letters. ,vol. 392, pp. 79- 83 ,(2006) , 10.1016/J.NEULET.2005.08.062